Deltex-3 inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of Deltex-3 (DTX3), a member of the Deltex family of proteins. Deltex-3 is known to play a critical role in regulating the Notch signaling pathway, a highly conserved cell communication system that governs cell fate decisions, differentiation, and proliferation. Deltex-3 functions as an E3 ubiquitin ligase, mediating the ubiquitination of various substrates, including components of the Notch pathway. This post-translational modification leads to the degradation or functional modulation of proteins, which influences signaling events within the cell. Inhibiting Deltex-3 affects its ability to regulate these processes, leading to altered cellular signaling and changes in the expression of target genes controlled by the Notch pathway.
Chemically, Deltex-3 inhibitors are designed to disrupt the interaction between Deltex-3 and its substrates, or to block its ubiquitin ligase activity by targeting the RING finger domain, which is essential for its catalytic function. These inhibitors may prevent the transfer of ubiquitin to target proteins, thus interfering with the regulation of protein stability and signaling cascades. The development of Deltex-3 inhibitors typically involves high-throughput screening, molecular docking studies, and structure-activity relationship (SAR) analysis to ensure high specificity and potency. By inhibiting Deltex-3, researchers can study its specific role in the Notch signaling pathway and other associated cellular processes, gaining valuable insights into how Deltex-3 contributes to the regulation of protein degradation and cell signaling dynamics. These inhibitors are important tools for investigating the broader regulatory networks in which Deltex-3 operates, particularly in relation to ubiquitination and its effects on cellular homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
May inhibit PI3K, potentially affecting Deltex-3 expression through interference with various cellular signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Could inhibit ERK/MAPK pathways, possibly affecting Deltex-3 expression regulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Might inhibit JNK, potentially altering transcription factors affecting Deltex-3 expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
May inhibit p38 MAPK, influencing signaling pathways regulating Deltex-3 expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Might inhibit PI3K, potentially impacting signaling pathways that modulate Deltex-3 expression. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
Could inhibit JAK-STAT pathway, influencing transcriptional regulation of Deltex-3. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
May inhibit mTOR pathways, possibly affecting Deltex-3 protein synthesis and expression. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Might inhibit ROCK, potentially affecting signaling pathways influencing Deltex-3 expression. | ||||||
ZM 336372 | 208260-29-1 | sc-202857 | 1 mg | $47.00 | 2 | |
Could inhibit RAF kinase, potentially impacting MAPK pathways and Deltex-3 expression. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
May inhibit PKC, possibly affecting signaling cascades that influence Deltex-3 expression. | ||||||